IL1B and chronic obstructive pulmonary disease: Interestingly, since the sensitivity to FP was unchanged when comparing the two study groups and LPS-stimulated PBMCs from COPD patients released higher levels of IL-1β and TNFα, the concentrations of these cytokines remained higher in the COPD group compared to healthy individuals even upon treatment with FP.